HEADER TRANSFERASE/TRANSFERASE INHIBITOR 15-JUN-17 5W5Q TITLE MAP4K4 IN COMPLEX WITH INHIBITOR COMPOUND 12 (N3-METHYL-10-(3-METHYL- TITLE 2 3-(5-METHYLOXAZOL-2-YL)BUT-1-YN-1-YL)-6,7-DIHYDRO-5H-5,7- TITLE 3 METHANOBENZO[C]IMIDAZO[1,2-A]AZEPINE-2,3-DICARBOXAMIDE) COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 4; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 2-328; COMPND 5 SYNONYM: HPK/GCK-LIKE KINASE HGK,MAPK/ERK KINASE KINASE KINASE 4, COMPND 6 MEKKK 4,NCK-INTERACTING KINASE; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAP4K4, HGK, KIAA0687, NIK; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS KINASE, TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.F.HARRIS,P.WU REVDAT 5 13-MAR-24 5W5Q 1 REMARK REVDAT 4 13-NOV-19 5W5Q 1 JRNL REVDAT 3 14-AUG-19 5W5Q 1 JRNL REVDAT 2 07-AUG-19 5W5Q 1 JRNL REVDAT 1 20-JUN-18 5W5Q 0 JRNL AUTH J.A.FENG,P.LEE,M.H.ALAOUI,K.BARRETT,G.CASTANEDO,R.GODEMANN, JRNL AUTH 2 P.MCEWAN,X.WANG,P.WU,Y.ZHANG,S.F.HARRIS,S.T.STABEN JRNL TITL STRUCTURE BASED DESIGN OF POTENT SELECTIVE INHIBITORS OF JRNL TITL 2 PROTEIN KINASE D1 (PKD1). JRNL REF ACS MED.CHEM.LETT. V. 10 1260 2019 JRNL REFN ISSN 1948-5875 JRNL PMID 31531194 JRNL DOI 10.1021/ACSMEDCHEMLETT.8B00658 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.W.FENG,P.LEE,M.H.ALAOUI,K.BARRETT,G.M.CASTANEDA, REMARK 1 AUTH 2 R.GODEMANN,P.MCEWAN,X.WANG,P.WU,Y.ZHANG,S.F.HARRIS, REMARK 1 AUTH 3 S.T.STABEN REMARK 1 TITL STRUCTURE BASED DESIGN OF POTENT SELECTIVE INHIBITORS OF REMARK 1 TITL 2 PROTEIN KINASE D1 (PKD1) REMARK 1 REF ACS MED.CHEM.LETT. 2019 REMARK 1 REFN ISSN 1948-5875 REMARK 1 DOI 10.1021/ACSMEDCHEMLETT.8B0065 REMARK 2 REMARK 2 RESOLUTION. 2.33 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.33 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 59.95 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 28690 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.211 REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.236 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.080 REMARK 3 FREE R VALUE TEST SET COUNT : 1457 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 14 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.33 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.42 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.85 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2968 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2336 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2810 REMARK 3 BIN R VALUE (WORKING SET) : 0.2306 REMARK 3 BIN FREE R VALUE : 0.2858 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.32 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 158 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4749 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 33 REMARK 3 SOLVENT ATOMS : 214 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 52.68 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 55.71 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 10.20320 REMARK 3 B22 (A**2) : -10.21950 REMARK 3 B33 (A**2) : 0.01630 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.327 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.390 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.229 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.371 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.229 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.932 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.923 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4913 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6646 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1761 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 121 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 730 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4913 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 626 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5763 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.07 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.96 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.35 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5W5Q COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-JUN-17. REMARK 100 THE DEPOSITION ID IS D_1000228489. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-MAY-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL12-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.1.27 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28901 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.330 REMARK 200 RESOLUTION RANGE LOW (A) : 90.650 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 25.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.33 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.60 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 6.50 REMARK 200 R MERGE FOR SHELL (I) : 0.44700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.13 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.16 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M MES PH 6.5, 35% PEG 3350, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 40.30550 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 45.32500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.83800 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 45.32500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 40.30550 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 44.83800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 SER A 1 REMARK 465 ALA A 2 REMARK 465 ASN A 3 REMARK 465 ASP A 4 REMARK 465 SER A 5 REMARK 465 PRO A 6 REMARK 465 ALA A 7 REMARK 465 LYS A 8 REMARK 465 SER A 9 REMARK 465 LEU A 10 REMARK 465 VAL A 11 REMARK 465 ASP A 12 REMARK 465 ILE A 13 REMARK 465 ASP A 14 REMARK 465 LEU A 15 REMARK 465 SER A 16 REMARK 465 PRO A 94 REMARK 465 PRO A 95 REMARK 465 GLY A 96 REMARK 465 HIS A 97 REMARK 465 LYS A 312 REMARK 465 ARG A 313 REMARK 465 GLY A 314 REMARK 465 GLU A 315 REMARK 465 LYS A 316 REMARK 465 ASP A 317 REMARK 465 GLU A 318 REMARK 465 THR A 319 REMARK 465 GLU A 320 REMARK 465 TYR A 321 REMARK 465 GLU A 322 REMARK 465 TYR A 323 REMARK 465 SER A 324 REMARK 465 GLY A 325 REMARK 465 SER A 326 REMARK 465 GLU A 327 REMARK 465 GLU A 328 REMARK 465 GLY A 329 REMARK 465 ASN A 330 REMARK 465 SER A 331 REMARK 465 GLY B 0 REMARK 465 SER B 1 REMARK 465 ALA B 2 REMARK 465 ASN B 3 REMARK 465 ASP B 4 REMARK 465 SER B 5 REMARK 465 PRO B 6 REMARK 465 ALA B 7 REMARK 465 LYS B 8 REMARK 465 SER B 9 REMARK 465 LEU B 10 REMARK 465 VAL B 11 REMARK 465 ASP B 12 REMARK 465 THR B 35 REMARK 465 TYR B 36 REMARK 465 LYS B 312 REMARK 465 ARG B 313 REMARK 465 GLY B 314 REMARK 465 GLU B 315 REMARK 465 LYS B 316 REMARK 465 ASP B 317 REMARK 465 GLU B 318 REMARK 465 THR B 319 REMARK 465 GLU B 320 REMARK 465 TYR B 321 REMARK 465 GLU B 322 REMARK 465 TYR B 323 REMARK 465 SER B 324 REMARK 465 GLY B 325 REMARK 465 SER B 326 REMARK 465 GLU B 327 REMARK 465 GLU B 328 REMARK 465 GLY B 329 REMARK 465 ASN B 330 REMARK 465 SER B 331 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 86 -61.58 -102.12 REMARK 500 ARG A 152 -12.67 75.06 REMARK 500 ASP A 153 53.02 -142.34 REMARK 500 ALA A 176 -168.93 64.99 REMARK 500 GLN A 177 -17.43 82.48 REMARK 500 ASP A 179 -3.96 60.84 REMARK 500 ARG B 152 -15.73 75.98 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9X4 A 401 DBREF 5W5Q A 2 328 UNP O95819 M4K4_HUMAN 2 328 DBREF 5W5Q B 2 328 UNP O95819 M4K4_HUMAN 2 328 SEQADV 5W5Q GLY A 0 UNP O95819 EXPRESSION TAG SEQADV 5W5Q SER A 1 UNP O95819 EXPRESSION TAG SEQADV 5W5Q GLY A 329 UNP O95819 EXPRESSION TAG SEQADV 5W5Q ASN A 330 UNP O95819 EXPRESSION TAG SEQADV 5W5Q SER A 331 UNP O95819 EXPRESSION TAG SEQADV 5W5Q GLY B 0 UNP O95819 EXPRESSION TAG SEQADV 5W5Q SER B 1 UNP O95819 EXPRESSION TAG SEQADV 5W5Q GLY B 329 UNP O95819 EXPRESSION TAG SEQADV 5W5Q ASN B 330 UNP O95819 EXPRESSION TAG SEQADV 5W5Q SER B 331 UNP O95819 EXPRESSION TAG SEQRES 1 A 332 GLY SER ALA ASN ASP SER PRO ALA LYS SER LEU VAL ASP SEQRES 2 A 332 ILE ASP LEU SER SER LEU ARG ASP PRO ALA GLY ILE PHE SEQRES 3 A 332 GLU LEU VAL GLU VAL VAL GLY ASN GLY THR TYR GLY GLN SEQRES 4 A 332 VAL TYR LYS GLY ARG HIS VAL LYS THR GLY GLN LEU ALA SEQRES 5 A 332 ALA ILE LYS VAL MET ASP VAL THR GLU ASP GLU GLU GLU SEQRES 6 A 332 GLU ILE LYS LEU GLU ILE ASN MET LEU LYS LYS TYR SER SEQRES 7 A 332 HIS HIS ARG ASN ILE ALA THR TYR TYR GLY ALA PHE ILE SEQRES 8 A 332 LYS LYS SER PRO PRO GLY HIS ASP ASP GLN LEU TRP LEU SEQRES 9 A 332 VAL MET GLU PHE CYS GLY ALA GLY SER ILE THR ASP LEU SEQRES 10 A 332 VAL LYS ASN THR LYS GLY ASN THR LEU LYS GLU ASP TRP SEQRES 11 A 332 ILE ALA TYR ILE SER ARG GLU ILE LEU ARG GLY LEU ALA SEQRES 12 A 332 HIS LEU HIS ILE HIS HIS VAL ILE HIS ARG ASP ILE LYS SEQRES 13 A 332 GLY GLN ASN VAL LEU LEU THR GLU ASN ALA GLU VAL LYS SEQRES 14 A 332 LEU VAL ASP PHE GLY VAL SER ALA GLN LEU ASP ARG THR SEQRES 15 A 332 VAL GLY ARG ARG ASN THR PHE ILE GLY THR PRO TYR TRP SEQRES 16 A 332 MET ALA PRO GLU VAL ILE ALA CYS ASP GLU ASN PRO ASP SEQRES 17 A 332 ALA THR TYR ASP TYR ARG SER ASP LEU TRP SER CYS GLY SEQRES 18 A 332 ILE THR ALA ILE GLU MET ALA GLU GLY ALA PRO PRO LEU SEQRES 19 A 332 CYS ASP MET HIS PRO MET ARG ALA LEU PHE LEU ILE PRO SEQRES 20 A 332 ARG ASN PRO PRO PRO ARG LEU LYS SER LYS LYS TRP SER SEQRES 21 A 332 LYS LYS PHE PHE SER PHE ILE GLU GLY CYS LEU VAL LYS SEQRES 22 A 332 ASN TYR MET GLN ARG PRO SER THR GLU GLN LEU LEU LYS SEQRES 23 A 332 HIS PRO PHE ILE ARG ASP GLN PRO ASN GLU ARG GLN VAL SEQRES 24 A 332 ARG ILE GLN LEU LYS ASP HIS ILE ASP ARG THR ARG LYS SEQRES 25 A 332 LYS ARG GLY GLU LYS ASP GLU THR GLU TYR GLU TYR SER SEQRES 26 A 332 GLY SER GLU GLU GLY ASN SER SEQRES 1 B 332 GLY SER ALA ASN ASP SER PRO ALA LYS SER LEU VAL ASP SEQRES 2 B 332 ILE ASP LEU SER SER LEU ARG ASP PRO ALA GLY ILE PHE SEQRES 3 B 332 GLU LEU VAL GLU VAL VAL GLY ASN GLY THR TYR GLY GLN SEQRES 4 B 332 VAL TYR LYS GLY ARG HIS VAL LYS THR GLY GLN LEU ALA SEQRES 5 B 332 ALA ILE LYS VAL MET ASP VAL THR GLU ASP GLU GLU GLU SEQRES 6 B 332 GLU ILE LYS LEU GLU ILE ASN MET LEU LYS LYS TYR SER SEQRES 7 B 332 HIS HIS ARG ASN ILE ALA THR TYR TYR GLY ALA PHE ILE SEQRES 8 B 332 LYS LYS SER PRO PRO GLY HIS ASP ASP GLN LEU TRP LEU SEQRES 9 B 332 VAL MET GLU PHE CYS GLY ALA GLY SER ILE THR ASP LEU SEQRES 10 B 332 VAL LYS ASN THR LYS GLY ASN THR LEU LYS GLU ASP TRP SEQRES 11 B 332 ILE ALA TYR ILE SER ARG GLU ILE LEU ARG GLY LEU ALA SEQRES 12 B 332 HIS LEU HIS ILE HIS HIS VAL ILE HIS ARG ASP ILE LYS SEQRES 13 B 332 GLY GLN ASN VAL LEU LEU THR GLU ASN ALA GLU VAL LYS SEQRES 14 B 332 LEU VAL ASP PHE GLY VAL SER ALA GLN LEU ASP ARG THR SEQRES 15 B 332 VAL GLY ARG ARG ASN THR PHE ILE GLY THR PRO TYR TRP SEQRES 16 B 332 MET ALA PRO GLU VAL ILE ALA CYS ASP GLU ASN PRO ASP SEQRES 17 B 332 ALA THR TYR ASP TYR ARG SER ASP LEU TRP SER CYS GLY SEQRES 18 B 332 ILE THR ALA ILE GLU MET ALA GLU GLY ALA PRO PRO LEU SEQRES 19 B 332 CYS ASP MET HIS PRO MET ARG ALA LEU PHE LEU ILE PRO SEQRES 20 B 332 ARG ASN PRO PRO PRO ARG LEU LYS SER LYS LYS TRP SER SEQRES 21 B 332 LYS LYS PHE PHE SER PHE ILE GLU GLY CYS LEU VAL LYS SEQRES 22 B 332 ASN TYR MET GLN ARG PRO SER THR GLU GLN LEU LEU LYS SEQRES 23 B 332 HIS PRO PHE ILE ARG ASP GLN PRO ASN GLU ARG GLN VAL SEQRES 24 B 332 ARG ILE GLN LEU LYS ASP HIS ILE ASP ARG THR ARG LYS SEQRES 25 B 332 LYS ARG GLY GLU LYS ASP GLU THR GLU TYR GLU TYR SER SEQRES 26 B 332 GLY SER GLU GLU GLY ASN SER HET 9X4 A 401 33 HETNAM 9X4 (5S,7S)-N~3~-METHYL-10-[3-METHYL-3-(5-METHYL-1,3- HETNAM 2 9X4 OXAZOL-2-YL)BUT-1-YN-1-YL]-6,7-DIHYDRO-5H-5,7- HETNAM 3 9X4 METHANOIMIDAZO[2,1-A][2]BENZAZEPINE-2,3-DICARBOXAMIDE FORMUL 3 9X4 C25 H25 N5 O3 FORMUL 4 HOH *214(H2 O) HELIX 1 AA1 GLU A 62 SER A 77 1 16 HELIX 2 AA2 ILE A 113 ASN A 119 1 7 HELIX 3 AA3 THR A 120 THR A 124 5 5 HELIX 4 AA4 LYS A 126 HIS A 147 1 22 HELIX 5 AA5 GLY A 183 THR A 187 5 5 HELIX 6 AA6 ALA A 196 ILE A 200 5 5 HELIX 7 AA7 ARG A 213 GLY A 229 1 17 HELIX 8 AA8 HIS A 237 ILE A 245 1 9 HELIX 9 AA9 SER A 259 LEU A 270 1 12 HELIX 10 AB1 ASN A 273 ARG A 277 5 5 HELIX 11 AB2 SER A 279 LYS A 285 1 7 HELIX 12 AB3 HIS A 286 ASP A 291 1 6 HELIX 13 AB4 ASN A 294 LYS A 311 1 18 HELIX 14 AB5 ASP B 61 LEU B 73 1 13 HELIX 15 AB6 ILE B 113 ASN B 119 1 7 HELIX 16 AB7 THR B 120 THR B 124 5 5 HELIX 17 AB8 LYS B 126 HIS B 147 1 22 HELIX 18 AB9 GLN B 177 VAL B 182 1 6 HELIX 19 AC1 GLY B 183 PHE B 188 5 6 HELIX 20 AC2 ALA B 196 ILE B 200 5 5 HELIX 21 AC3 ARG B 213 GLY B 229 1 17 HELIX 22 AC4 HIS B 237 ILE B 245 1 9 HELIX 23 AC5 SER B 259 LEU B 270 1 12 HELIX 24 AC6 ASN B 273 ARG B 277 5 5 HELIX 25 AC7 SER B 279 LYS B 285 1 7 HELIX 26 AC8 HIS B 286 ASP B 291 1 6 HELIX 27 AC9 ASN B 294 LYS B 311 1 18 SHEET 1 AA1 5 PHE A 25 ASN A 33 0 SHEET 2 AA1 5 GLN A 38 HIS A 44 -1 O LYS A 41 N GLU A 29 SHEET 3 AA1 5 LEU A 50 VAL A 58 -1 O ALA A 51 N GLY A 42 SHEET 4 AA1 5 ASP A 99 MET A 105 -1 O LEU A 101 N MET A 56 SHEET 5 AA1 5 TYR A 85 LYS A 91 -1 N GLY A 87 O VAL A 104 SHEET 1 AA2 3 GLY A 111 SER A 112 0 SHEET 2 AA2 3 VAL A 159 LEU A 161 -1 O LEU A 161 N GLY A 111 SHEET 3 AA2 3 VAL A 167 LEU A 169 -1 O LYS A 168 N LEU A 160 SHEET 1 AA3 5 PHE B 25 GLY B 32 0 SHEET 2 AA3 5 GLN B 38 HIS B 44 -1 O LYS B 41 N GLU B 29 SHEET 3 AA3 5 LEU B 50 VAL B 58 -1 O ALA B 51 N GLY B 42 SHEET 4 AA3 5 ASP B 99 GLU B 106 -1 O LEU B 101 N MET B 56 SHEET 5 AA3 5 TYR B 85 LYS B 91 -1 N PHE B 89 O TRP B 102 SHEET 1 AA4 3 GLY B 111 SER B 112 0 SHEET 2 AA4 3 VAL B 159 LEU B 161 -1 O LEU B 161 N GLY B 111 SHEET 3 AA4 3 VAL B 167 LEU B 169 -1 O LYS B 168 N LEU B 160 SITE 1 AC1 14 VAL A 31 ASN A 33 VAL A 39 ALA A 52 SITE 2 AC1 14 LEU A 73 ALA A 83 LEU A 103 GLU A 106 SITE 3 AC1 14 PHE A 107 CYS A 108 GLN A 157 LEU A 160 SITE 4 AC1 14 VAL A 170 ASP A 171 CRYST1 80.611 89.676 90.650 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012405 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011151 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011031 0.00000